Targeted agents in cervical cancer: beyond bevacizumab
G Marquina, A Manzano, A Casado - Current oncology reports, 2018 - Springer
Cervical cancer constitutes a leading cause of morbidity and cancer deaths in women
throughout the world. Approximately two thirds of the patients are diagnosed with locally …
throughout the world. Approximately two thirds of the patients are diagnosed with locally …
Targeted Agents in Cervical Cancer: Beyond Bevacizumab.
G Marquina, A Manzano, A Casado - Current Oncology Reports, 2018 - europepmc.org
Cervical cancer constitutes a leading cause of morbidity and cancer deaths in women
throughout the world. Approximately two thirds of the patients are diagnosed with locally …
throughout the world. Approximately two thirds of the patients are diagnosed with locally …
Targeted Agents in Cervical Cancer: Beyond Bevacizumab
G Marquina, A Manzano… - Current oncology …, 2018 - pubmed.ncbi.nlm.nih.gov
Cervical cancer constitutes a leading cause of morbidity and cancer deaths in women
throughout the world. Approximately two thirds of the patients are diagnosed with locally …
throughout the world. Approximately two thirds of the patients are diagnosed with locally …
Targeted Agents in Cervical Cancer: Beyond Bevacizumab
G Marquina, A Manzano… - Current Oncology …, 2018 - search.proquest.com
Cervical cancer constitutes a leading cause of morbidity and cancer deaths in women
throughout the world. Approximately two thirds of the patients are diagnosed with locally …
throughout the world. Approximately two thirds of the patients are diagnosed with locally …